Tether cooperated with Turkish regulators to freeze over $544 million in crypto assets.

The post SEC decisions scrutinized as senator seeks records on crypto enforcement rollbacks appeared on BitcoinEthereumNews.com. U.S. securities regulators have

The post Crypto Supercycle in 2025? DeepSeek Ranks the Best Altcoins to Buy Right Now appeared on BitcoinEthereumNews.com. Crypto Supercycle in 2025? DeepSeek Ranks the Best Altcoins to Buy Right Now Sign Up for Our Newsletter! For updates and exclusive offers enter your email. As a crypto writer, Krishi splits his time between decoding the chaos of the markets and writing about it in a way that doesn’t put you to sleep. He’s been at it for nearly two years in the crypto trenches. Yes, he regrets missing the magnificent rallies that came before that (who doesn’t!), but he’s more than ready to put his money where his words are. Before diving headfirst into crypto, Krishi spent over five years writing for some of the biggest names in tech, including TechRadar, Tom’s Guide, and PC Gaming, covering everything from gadgets and cybersecurity to gaming and software. When he’s not scouring and writing about the latest happenings in crypto, Krishi trades the forex market while keeping crypto in his long-term HODL plans. He’s a Bitcoin believer, though he never lets that bias creep into his writing. This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Center or Cookie Policy. I Agree Source: https://bitcoinist.com/crypto-supercycle-2025-best-altcoins-to-buy-now-deepseek/

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…